Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Corporate earnings weigh on stocks ahead of Fed minutes

Tue, 20th Aug 2013 11:41

A number of poorly-received results from blue-chip companies and ongoing concerns about the future of US stimulus weighed heavily on markets on Tuesday morning, dragging the FTSE 100 to levels not seen in over six weeks.London's benchmark index reached an intraday low of around 6,400 early on before trimming losses slightly by midday; still, the last time it closed lower was on July 5th when it finished the day at 6,375.52.Rising US bond yields and speculation about an impending tapering of asset purchases by the Federal Reserve have hit market sentiment over recent weeks. Investors are now choosing to adopt a cautious approach ahead of the minutes of the Federal Open Market Committee (FOMC) meeting due out tomorrow."We're seeing a lot more risk aversion in the markets now, with Asian indices plummeting over night and European stocks following suit this morning. With very little data out over night and again today, investors are clearly preparing themselves ahead of the Fed minutes which will be released on Wednesday," said Market Analyst Craig Erlam from Alpari.While Erlam isn't expecting any surprises from the minutes - given that a potential decision to taper still remains dependent on incoming economic data - he said: "That has never stopped the markets panicking in the past and doesn't look like stopping them now. The markets hate uncertainty."FTSE 100: Wood Group, CRH, miners drop sharplyOil and gas services company Wood Group slumped this morning after scaling back its full-year EBITA growth guidance for its engineering division from 15% to "10-15%", reflecting some project delays and further weakening in Canada. EBITA in the first half was up 18.6% year-on-year.CRH also fell sharply after swinging to a loss for the half-year period. The building materials firm reported a loss before tax of €71m, down from €102m the year before, while sales fell 3.0% to €8.01bn.Mining stocks were also out of favour today as results from BHP Billiton and Glencore Xstrata failed to impress. BHP said lower commodity prices wiped $8.9bn off its underlying earnings which plunged 22.4% in the year to the end of June, while Glencore Xstrata was forced to write down $7.7bn in assets as it reported a 9.0% drop in first-half adjusted EBITDA.Even housebuilder Persimmon fell into the red by midday despite a strong jump early on. The company said that first-half profits jumped 38% and its order book was running 21% ahead of last year as the government's 'Help to Buy' scheme boosted demand.Defensive stocks were in demand today as relatively 'riskier' assets (such as those in the resources sectors) were sold off. Telecom giant BT, utilities peers National Grid and United Utilities and pharmaceutical giant GlaxoSmithKline were all making gains this morning.Meggitt, the engineering group working in the aerospace, defence and energy markets, was slightly higher after Investec upgraded the stock from 'add' to 'buy', saying it still sees further upside even after a strong performance this year.FTSE 100 - RisersCompass Group (CPG) 869.50p +1.40%BT Group (BT.A) 326.30p +1.27%GlaxoSmithKline (GSK) 1,659.00p +0.85%National Grid (NG.) 739.50p +0.82%Meggitt (MGGT) 536.50p +0.75%Aggreko (AGK) 1,680.00p +0.60%British American Tobacco (BATS) 3,410.00p +0.49%Tate & Lyle (TATE) 824.50p +0.49%Vodafone Group (VOD) 190.70p +0.45%British Land Co (BLND) 570.50p +0.44%FTSE 100 - FallersWood Group (John) (WG.) 831.50p -7.92%CRH (CRH) 1,363.00p -4.42%Vedanta Resources (VED) 1,153.00p -3.92%Prudential (PRU) 1,146.00p -3.37%Glencore Xstrata (GLEN) 292.25p -3.21%Standard Chartered (STAN) 1,477.00p -2.89%Lloyds Banking Group (LLOY) 73.08p -2.56%BHP Billiton (BLT) 1,907.50p -2.48%GKN (GKN) 332.10p -2.24%G4S (GFS) 241.50p -1.91%FTSE 250 - RisersFisher (James) & Sons (FSJ) 1,054.00p +5.56%Ladbrokes (LAD) 200.00p +4.44%Crest Nicholson Holdings (CRST) 331.00p +2.41%Hikma Pharmaceuticals (HIK) 1,087.00p +1.40%NMC Health (NMC) 334.50p +1.36%Barr (A.G.) (BAG) 565.00p +1.35%Britvic (BVIC) 562.50p +1.35%Keller Group (KLR) 1,056.00p +1.25%Centamin (DI) (CEY) 37.48p +0.75%Lancashire Holdings Limited (LRE) 750.00p +0.74%FTSE 250 - FallersBrewin Dolphin Holdings (BRW) 259.00p -5.99%Computacenter (CCC) 510.00p -5.38%Hochschild Mining (HOC) 222.10p -4.64%Evraz (EVR) 117.50p -4.55%Ashmore Group (ASHM) 338.40p -4.05%Fenner (FENR) 345.50p -3.81%Inchcape (INCH) 610.50p -3.63%Perform Group (PER) 530.00p -3.55%Utilico Emerging Markets Ltd (DI) (UEM) 167.50p -3.29%Menzies(John) (MNZS) 735.50p -3.16%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.